Madrigal Pharmaceuticals Inc (MDGL)
Long-Term Debt
$346.72M
Quarterly · Period ending: · USD
MDGL Long-Term Debt
Latest reported$346.72Mperiod ending
Latest reported$346.72Mperiod ending
MDGL Quarterly Long-Term Debt ($1.57M → $346.72M)
Quarterly long-term debt
High-resolution chart · PNG
MDGL long-term debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Long-Term Debt (USD) |
|---|---|
| 346,717,000 | |
| 345,614,000 | |
| 353,343,000 | |
| 345,319,000 | |
| 122,900,000 | |
| 118,755,000 | |
| 118,587,000 | |
| 118,263,000 | |
| 117,507,000 | |
| 117,180,000 | |
| 116,666,000 | |
| 116,050,000 | |
| 99,249,000 | |
| 83,965,000 | |
| 49,289,000 | |
| 49,054,000 | |
| 48,848,000 | |
| 283,000 | |
| 387,000 | |
| 491,000 | |
| 594,000 | |
| 387,000 | |
| 468,000 | |
| 548,000 | |
| 197,000 | |
| 279,000 | |
| 361,000 | |
| 441,000 | |
| 520,000 | |
| 598,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 11,000 | |
| 32,000 | |
| 2,365,000 | |
| 4,650,000 | |
| 6,967,000 | |
| 9,282,000 | |
| 11,595,000 | |
| 13,905,000 | |
| 16,120,000 | |
| 18,417,000 | |
| 20,545,000 | |
| 4,465,000 | |
| 6,458,000 | |
| 8,446,000 | |
| 10,427,000 | |
| 12,402,000 | |
| 12,171,000 | |
| 13,835,000 | |
| 11,494,000 | |
| 11,693,000 | |
| 13,370,000 | |
| 319,000 | |
| 528,000 | |
| 799,000 | |
| 1,092,000 | |
| 1,397,000 | |
| 10,258,000 | |
| 8,306,000 | |
| 2,301,000 | |
| 2,843,000 | |
| 2,563,000 | |
| 2,815,000 | |
| 3,119,000 | |
| 3,268,000 | |
| 3,368,000 | |
| 3,170,000 | |
| 3,423,000 | |
| 4,259,000 | |
| 1,572,000 |